| Omar F Shams, MD | |
|
13700 St Francis Blvd, Suite 600, Midlothian, VA 23114-3222 | |
| (804) 794-6400 | |
| (804) 897-0910 |
| Full Name | Omar F Shams |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 19 Years |
| Location | 13700 St Francis Blvd, Midlothian, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093906133 | NPI | - | NPPES |
| C09462 | Other | VA | GROUP PTAN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Healthcare White Oak Medical Center | Silver spring, MD | Hospital |
| Adventist Healthcare Shady Grove Medical Center | Rockville, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adventist Physician Services Inc | 4284631540 | 123 |
News Archive
Illumina, Inc. today announced shipment of HiScanSQ, the first instrument to integrate microarray analysis and next-generation sequencing in a modular design that can evolve with changing research needs.
The Max Planck Florida Institute for Neuroscience, the first and only U.S. extension of the prestigious Max Planck Society, today announced it has received approximately $1,257,500 in grant funding from prestigious national and international organizations to fund research into Parkinson-s, epilepsy and other neurological disorders.
The insurance industry won a major lobbying victory Monday after the Obama administration backtracked on an earlier plan to cut Medicare Advantage payments to insurers by 2.2 percent in 2014 and instead decided to give them a 3.3 percent increase.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, and muscle, today announced preliminary results from the ACE-031 Phase 1 single dose clinical trial demonstrating that ACE-031 increased lean body mass and muscle volume. The results from this randomized, placebo-controlled study were presented at the 14th International Congress of the World Muscle Society in Geneva, Switzerland.
› Verified 7 days ago
| Entity Name | Adventist Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376623207 PECOS PAC ID: 4284631540 Enrollment ID: O20061030000122 |
News Archive
Illumina, Inc. today announced shipment of HiScanSQ, the first instrument to integrate microarray analysis and next-generation sequencing in a modular design that can evolve with changing research needs.
The Max Planck Florida Institute for Neuroscience, the first and only U.S. extension of the prestigious Max Planck Society, today announced it has received approximately $1,257,500 in grant funding from prestigious national and international organizations to fund research into Parkinson-s, epilepsy and other neurological disorders.
The insurance industry won a major lobbying victory Monday after the Obama administration backtracked on an earlier plan to cut Medicare Advantage payments to insurers by 2.2 percent in 2014 and instead decided to give them a 3.3 percent increase.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, and muscle, today announced preliminary results from the ACE-031 Phase 1 single dose clinical trial demonstrating that ACE-031 increased lean body mass and muscle volume. The results from this randomized, placebo-controlled study were presented at the 14th International Congress of the World Muscle Society in Geneva, Switzerland.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Omar F Shams, MD 13700 St Francis Blvd, Suite 600, Midlothian, VA 23114-3222 Ph: (804) 794-6400 | Omar F Shams, MD 13700 St Francis Blvd, Suite 600, Midlothian, VA 23114-3222 Ph: (804) 794-6400 |
News Archive
Illumina, Inc. today announced shipment of HiScanSQ, the first instrument to integrate microarray analysis and next-generation sequencing in a modular design that can evolve with changing research needs.
The Max Planck Florida Institute for Neuroscience, the first and only U.S. extension of the prestigious Max Planck Society, today announced it has received approximately $1,257,500 in grant funding from prestigious national and international organizations to fund research into Parkinson-s, epilepsy and other neurological disorders.
The insurance industry won a major lobbying victory Monday after the Obama administration backtracked on an earlier plan to cut Medicare Advantage payments to insurers by 2.2 percent in 2014 and instead decided to give them a 3.3 percent increase.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, and muscle, today announced preliminary results from the ACE-031 Phase 1 single dose clinical trial demonstrating that ACE-031 increased lean body mass and muscle volume. The results from this randomized, placebo-controlled study were presented at the 14th International Congress of the World Muscle Society in Geneva, Switzerland.
› Verified 7 days ago
Dr. Jennifer Simpliciano, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 611 Watkins Centre Pkwy Ste 250, Midlothian, VA 23114 Phone: 804-423-8470 Fax: 804-423-8471 | |
Dr. Vicki B Latham-solomon, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 13901 Coalfield Commons Pl Ste 201, Midlothian, VA 23114 Phone: 804-420-1200 Fax: 804-344-0980 | |
Mark A Gentz, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 13700 St Francis Blvd, Suite 505, Midlothian, VA 23114 Phone: 804-601-0609 Fax: 804-594-7424 | |
Shashi Kumar Prabhakar, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 13700 St Francis Blvd, Suite 600, Midlothian, VA 23114 Phone: 804-794-6400 Fax: 804-897-0910 | |
Francesca Levine Glynn, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 13700 St Francis Blvd, Suite 510, Midlothian, VA 23114 Phone: 804-423-8470 Fax: 804-423-8471 | |
Morgan L. Vargo, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2384 Colony Crossing Pl, Midlothian, VA 23112 Phone: 804-423-3636 |